Evidence map›Paper›PMID 26338244›Full record

ArticleBMJ case reports2015

Primary bone metastasis as first manifestation of an unknown primary tumour.

Rafael García Carretero, Marta Romero Brugera, Noelia Rebollo-Aparicio, Liliam El Bouayadi Mohamed

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Using the journalJournal of the Medical Library Association : JMLA · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rafael García CarreteroMostoles General Hospital, Mostoles, Madrid, Spain.ORCID http://orcid.org/0000-0001-7532-4585
Marta Romero BrugeraDepartment of Internal Medicine, Mostoles General Hospital, Mostoles, Madrid, Spain.
Noelia Rebollo-AparicioDepartment of Internal Medicine, Mostoles General Hospital, Mostoles, Madrid, Spain.
Liliam El Bouayadi MohamedDepartment of Pathology, Mostoles General Hospital, Mostoles, Madrid, Spain.
Hospital Universitario de Móstoles · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unknown primary tumour refers to a group of cancers for which the anatomical site of origin remains occult after detailed investigations. Thanks to sophisticated imaging, immunohistochemical testing and molecular-profiling tools, there is a more accurate approach to unknown primary cancer. Metastasis to bone is not a rare phenomenon, because any tumour can metastasise to bone, so it is a common clinical scenario. The role of clinical history, physical examination, laboratory tests, radiographic studies and immunohistochemistry is critical for a successful diagnostic strategy. Subsets of unknown primary cancers can be identified primarily on the basis of histopathological findings, the pattern of spread and serum markers. New immunohistochemical markers and tissue-of-origin profiles may establish presumable primary sites to unknown primary cancer on the basis of immunohistochemical and molecular patterns. We present a case of a 57-year-old woman without a cancer history, who had primary bone metastasis as the first manifestation of an occult primary tumour.

Indexed as

Neoplasms, Unknown PrimaryBiopsyBone NeoplasmsFatal OutcomeFemaleHumansMiddle AgedTomography, X-Ray Computed

Identifiers

PMID26338244
PMCPMC4567768
OpenAlexW2160801361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.